There’s been a lot of grim news lately about HIV and AIDS: Rising infections among high-risk U.S. communities, continued risk behaviors, and plague-level infection rates across sub-Saharan Africa. In ...
A federal grant for HIV research is part of $15.7 million the National Institutes for Health awarded to the Wertheim UF ...
The findings confirm that allosteric inhibition of integrase is clinically viable, validating a new antiviral drug class.
The two-drug regimen dolutegravir/lamivudine is as effective as the three-drug regimen dolutegravir plus tenofovir ...
In the hunt for a remedy, when the baton is passed from dedicated academic scientists to an innovative company to trusted community advocates, outcomes for society can be especially powerful. Today, ...
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...
2don MSNOpinion
HIV knows no borders, and the Trump administration's new strategy leaves Americans vulnerable, expert explains
Protecting public health abroad benefits Americans. In a globalized world, diseases and their social and economic impacts do ...
Schools are intensifying drug and HIV awareness education to address increasing health and social risks among students, ...
Hosted on MSN
Is there a way to stop HIV? This Jupiter lab hopes a drug it's developing will come close
Scientists at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology in Jupiter have received $15.7 million in four separate federal grants to help with their research over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback